NCT01954004View on ClinicalTrials.gov

Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients

CompletedOBSERVATIONAL
Enrollment

1,270

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Prostate Cancer
Trial Locations (1)

Unknown

Salt Lake City

All Listed Sponsors
lead

Myriad Genetic Laboratories, Inc.

INDUSTRY

NCT01954004 - Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients | Biotech Hunter | Biotech Hunter